Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors

Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors

<p>Glioblastoma patient characteristics (DFCI)</p>

Сохранить в:
Библиографические подробности
Главный автор: Joseph Toker (15399882) (author)
Другие авторы: J. Bryan Iorgulescu (15030477) (author), Alexander L. Ling (15399885) (author), Genaro R. Villa (15399888) (author), Josephina A.M.A. Gadet (15399891) (author), Laxmi Parida (15112564) (author), Gad Getz (14945542) (author), Catherine J. Wu (14944480) (author), David A. Reardon (15043854) (author), E. Antonio Chiocca (15399894) (author), Marco Mineo (15399897) (author)
Опубликовано: 2025
Предметы:
Cancer
Cancer Detection and Diagnosis
Immuno-oncology
Biomarkers
CNS Cancers
Gliomas, Glioblastomas
Immunotherapy
Checkpoint blockade
Skin Cancers
Melanoma
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!
Описание
Итог:<p>Glioblastoma patient characteristics (DFCI)</p>

Схожие документы